Gajanan Hospitals Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 29-07-2024
- Paid Up Capital ₹ 7.28 M
as on 29-07-2024
- Company Age 21 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.67 Cr
as on 29-07-2024
- Revenue 3.33%
(FY 2023)
- Profit -90.56%
(FY 2023)
- Ebitda 87.06%
(FY 2023)
- Net Worth -18.53%
(FY 2023)
- Total Assets 0.99%
(FY 2023)
About Gajanan Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 7.28 M.
The company currently has active open charges totaling ₹7.67 Cr.
Akkaraju Bharat, Akkaraju Rao, Thirumalai Piramanayagam, and Six other members serve as directors at the Company.
- CIN/LLPIN
U85110TN2003PTC052023
- Company No.
052023
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Nov 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai-600 045., Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Gajanan Hospitals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Akkaraju Rao  | Managing Director | 27-Nov-2003 | Current |
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Akkaraju Bharat | Whole-Time Director | 27-Nov-2003 | Current |
| Thirumalai Piramanayagam | Director | 31-Mar-2006 | Current |
| Gopalakrishnan Meenakshi | Whole-Time Director | 27-Nov-2003 | Current |
| Arcot Chandrika | Director | 31-Mar-2006 | Current |
| Chinnasamy Thangadorai | Director | 31-Mar-2006 | Current |
| Sundaram Rajendran | Director | 27-Aug-2009 | Current |
Financial Performance of Gajanan Hospitals.
Gajanan Hospitals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.33% increase. The company also saw a substantial fall in profitability, with a 90.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gajanan Hospitals?
In 2023, Gajanan Hospitals had a promoter holding of 59.11% and a public holding of 40.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 16 Nov 2016 | ₹5.67 Cr | Open |
Indian Overseas Bank Creation Date: 29 Sep 2014 | ₹2.00 Cr | Open |
How Many Employees Work at Gajanan Hospitals?
Gajanan Hospitals has a workforce of 225 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gajanan Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gajanan Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
